Most importantly, the vast majority reveal the poor prognostic impact of L1CAM after adjusting for other factors in multivariate analysis, and they repeatedly show its prognostic significance for stage I endometrioid adenocarcinomas, the most heterogenous group of endometrial tumors lacking sufficient prognostic tools. This evidence concerns the gene L1CAM and endometrioid adenocarcinoma.